Ravindra Uppaluri, MD, PhD, discusses findings from the KEYNOTE-689 trial in adult patients with resectable, locally advanced head and neck squamous cell carcinoma.

AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Amplia Therapeutics has reported a 'complete response' from a patient with metastasised pancreatic cancer: "A rare event". ..

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...